Article
The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
30 Sept 2018
Abstract excerpt
Our understanding of the mechanisms underlying Parkinson's disease, the once archetypical nongenetic neurogenerative disorder, has dramatically increased with the identification of α-synuclein and LRRK2 pathogenic mutations. While α-synuclein protein composes the aggregates that can spread through much of the brain in disease, LRRK2 encodes a multidomain dual-enzyme distinct from any other protein linked to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
